Fresh analysis reveals that patients who come off blockbuster weight-loss injections like Wegovy and Mounjaro may regain shed pounds at a significantly accelerated pace than those who end conventional lifestyle plans.
Published data in a major medical journal demonstrates that while overweight individuals often shed a large proportion of their body weight while undergoing treatment, the mass returns at an average rate of 0.8 kg per month once they quit.
"People purchasing such medications need to be informed of the risk of rapid weight regain when the therapy concludes," cautioned researcher Dr. Susan Jebb.
This pace of recovery means a return to starting weight in about 18 months.
Comparing Approaches
The study, which reviewed 37 of studies involving over 9,000 of patients, contrasted the outcomes of the injectable medications with other pills.
Researchers emphasize that people who lose weight through dieting generally see a slower creep back—approximately 100 grams monthly—post-intervention.
Explaining the Fast Regain
Nutrition scientists believe the way of the drugs is key to understanding the heightened rebound.
GLP-1 drugs mimic a natural hormone called GLP-1, which helps regulate hunger.
"Artificially providing the hormone levels far above than the body's typical production might result in the body to produce less of its own natural GLP-1, and could lessen sensitivity to its effects," noted Dr. Adam Collins, a nutrition expert.
"Discontinuation of this medication results in hunger is unsuppressed, making overeating a significant risk."
An Ongoing Issue?
Health authorities suggest the jabs for individuals with obesity-related health risks, alongside recommended lifestyle changes.
Many experts argue that, due to the high risk of relapse, the treatment should be considered ongoing.
This view is echoed by drug manufacturers, who say that the results "highlight the long-term character of obesity," similar to managing diseases like diabetes.
Patient Experiences
Users who have come off the medication describe a sudden return of cravings.
"I experienced a switch activating and you're instantly extremely hungry," described a patient.
The struggle is worsened if users have not established sustainable lifestyle or habit modifications during therapy.
Widespread Adoption
Survey data show that a significant number of people in the UK have tried these injections in the last 12 months, with desire continuing to grow.
- Adoption is more common among females compared to men.
- The 40s and 50s demographic shows the greatest level of interest.
- Many obtain the drugs through private prescriptions rather than public health services.
Ultimately, experts emphasize that while these medications are potent agents for shedding pounds, they are not a standalone solution and long-term success relies on ongoing lifestyle support.